Research partnership established between Infinimmune and Immunome in scientific pursuit
Infinimmune, a pioneering biotechnology company, has announced a research collaboration agreement with Immunome, Inc. (NASDAQ: IMNM). This partnership is aimed at the discovery and optimization of novel antibodies, designed to drug new and existing targets with improved safety and efficacy.
Infinimmune, founded by a world-class, multidisciplinary team of scientists and technologists, is reinventing antibody discovery with an end-to-end platform. The company is responsible for antibody discovery and optimization under the terms of the agreement, while Immunome will handle the development and commercialization of any resulting candidates.
Infinimmune's approach to antibody drug discovery and development is novel. The company's GLIMPSETM platform is trained on its proprietary human antibody data, allowing it to systematically improve key properties like affinity, stability, and developability while maintaining human-like characteristics. This collaboration is expected to demonstrate how Infinimmune's GLIMPSETM platform can optimize and enhance existing antibodies with unprecedented speed.
Immunome, Inc. is led by CEO and co-founder Daniel Rotroff. The financial terms of the deal were not disclosed. Under the agreement, Immunome will receive target exclusivity.
Infinimmune can be followed on LinkedIn (@infinimmune) and its website, infinimmune.com, provides more information about the company and its work. The biotech company is also partnering with pharmaceutical companies to advance their antibody programs.
This collaboration marks an exciting step forward in the field of antibody drug discovery and development, with the potential to bring new and improved treatments to patients in the future.
Read also:
- Trump's SNAP reductions and New York City Council's grocery delivery legislation: Problems for city residents highlighted
- Reducing dental expenses for elderlies in Sweden: Over 50% cut in charges for pensioners by the government
- Forty-year-old diet: A list of meal choices to savor
- Exiled Life's Conundrum: A Blend of Liberation, Disillusionment, and Distress
